Seqirus, part of the CSL Group, is the new global company created from the combined strength and expertise of bioCSL and the influenza vaccines business formerly owned by Novartis.
Our ambition is to become and “Enterprise Capital of Europe” delivering increased business density, growth and employment.
Liverpool City Region has a diverse and resilient business community in a wide range of sectors, however we require a coherent approach to the wide range of factors that impact on business formation, survival, investment and growth.
To create a dynamic enterprise ecosystem, we have identified a series of ambitions and initiatives
Our approach will be integrated into work in the City Region’s key growth sectors. For each sector our ambition is to raise productivity and accelerate growth through investment in facilities, infrastructure, networks, people and innovation. Our key growth sectors are: